CRVS R&D Expenses
Corvus Pharmaceuticals Inc · R&D Expenses
CRVS R&D Expenses
Latest reported$45.53Mperiod ending
CRVS TTM R&D Expenses ($11.35M → $45.53M)
TTM R&D Expenses
High-resolution chart · PNG
CRVS r&d expenses history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | R&D Expenses (USD) |
|---|---|
| 45,532,000 | |
| 37,441,000 | |
| 33,719,000 | |
| 29,754,000 | |
| 26,522,000 | |
| 22,763,000 | |
| 19,385,000 | |
| 17,410,000 | |
| 16,153,000 | |
| 16,007,000 | |
| 16,526,000 | |
| 16,607,000 | |
| 23,007,000 | |
| 23,962,000 | |
| 24,468,000 | |
| 25,176,000 | |
| 21,802,000 | |
| 25,985,000 | |
| 29,115,000 | |
| 31,518,000 | |
| 31,146,000 | |
| 29,897,000 | |
| 31,830,000 | |
| 33,559,000 | |
| 35,936,000 | |
| 38,719,000 | |
| 37,975,000 | |
| 37,449,000 | |
| 36,827,000 | |
| 35,902,000 | |
| 38,586,000 | |
| 39,880,000 | |
| 42,239,000 | |
| 44,910,000 | |
| 46,304,000 | |
| 45,747,000 | |
| 42,721,000 | |
| 37,454,000 | |
| 29,354,000 | |
| 25,132,000 | |
| 19,939,000 | |
| 14,825,000 | |
| 11,352,000 | |
| 6,484,455 |